Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 37,221 | 34,259 | 32,489 | 28,362 | 27,231 |
| Operating Income | -37,221 | -34,259 | -32,489 | -28,362 | -27,231 |
| Other Income | 2,233 | 2,221 | 1,707 | 1,044 | 762 |
| Pre-tax Income | -34,988 | -32,038 | -30,782 | -27,318 | -26,469 |
| Income Tax | 190 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -35,178 | -32,038 | -30,782 | -27,318 | -26,469 |
| Net Income | $-35,178 | $-32,038 | $-30,782 | $-27,318 | $-26,469 |
| EPS Basic Total Ops | -0.71 | -0.65 | -0.64 | -0.58 | -0.57 |
| EPS Basic Continuous Ops | -0.71 | -0.65 | -0.63 | -0.58 | -0.57 |
| EPS Diluted Total Ops | -0.71 | -0.65 | -0.64 | -0.58 | -0.57 |
| EPS Diluted Continuous Ops | -0.71 | -0.65 | -0.63 | -0.58 | -0.57 |
| EBITDA(a) | $-35,830 | $-33,108 | $-31,419 | $-27,329 | $-26,342 |